These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31084)

  • 21. Systemic antibiotics for treatment of the conjunctivitis-otitis media syndrome.
    Bodor FF
    Pediatr Infect Dis J; 1989 May; 8(5):287-90. PubMed ID: 2631693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of otitis media with cefaclor, a new oral cephalosporin.
    Aronovitz GH
    South Med J; 1980 Nov; 73(11):1447-9. PubMed ID: 6969442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
    Sakata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
    Zielnik-Jurkiewicz B; Bielicka A
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2129-33. PubMed ID: 26454530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial treatment of otitis media.
    Giebink GS; Canafax DM
    Semin Respir Infect; 1991 Jun; 6(2):85-93. PubMed ID: 1771307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythromycin-sulfisoxazole for persistent acute otitis media due to ampicillin-resistant Haemophilus influenzae.
    Rodriguez WJ; Schwartz RH; Khan WN; Gold AJ
    Pediatr Infect Dis; 1983; 2(1):27-9. PubMed ID: 6601265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriology of acute otitis media in Japanese children.
    Fujita K; Iseki K; Yoshioka H; Sasaki T; Ando T; Nakamura M
    Am J Dis Child; 1983 Feb; 137(2):152-4. PubMed ID: 6336890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of otitis media.
    Ramakrishnan K; Sparks RA; Berryhill WE
    Am Fam Physician; 2007 Dec; 76(11):1650-8. PubMed ID: 18092706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical isolates and treatment of acute otitis media].
    Kataoka S
    Jpn J Antibiot; 2001 May; 54 Suppl B():30-3. PubMed ID: 12638139
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children.
    Dagan R; Leibovitz E; Fliss DM; Leiberman A; Jacobs MR; Craig W; Yagupsky P
    Antimicrob Agents Chemother; 2000 Jan; 44(1):43-50. PubMed ID: 10602721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media.
    Leibovitz E; Piglansky L; Raiz S; Greenberg D; Yagupsky P; Press J; Fliss DM; Leiberman A; Dagan R
    Pediatr Infect Dis J; 1998 Dec; 17(12):1126-31. PubMed ID: 9877360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of acute otitis media caused by resistant pneumococci in infants.
    Roger G; Carles P; Pangon B; Thien HV; Polonovski JM; Begue P; Garabedian EN
    Pediatr Infect Dis J; 1998 Jul; 17(7):631-8. PubMed ID: 9686731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute otitis media in older children and adults treated with penicillin or erythromycin.
    Rosén C; Forsgren A; Löfkvist T; Walder M
    Acta Otolaryngol Suppl; 1984; 407():23-5. PubMed ID: 6437133
    [No Abstract]   [Full Text] [Related]  

  • 38. Ampicillin-resistant Haemophilus influenzae. 2. Therapeutic considerations.
    Thornsberry C; McDougal LK
    Postgrad Med; 1982 Jan; 71(1):149-51, 154-5. PubMed ID: 6976567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo sensitivity test in otitis media: efficacy of antibiotics.
    Howie VM; Dillard R; Lawrence B
    Pediatrics; 1985 Jan; 75(1):8-13. PubMed ID: 3871251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of otitis media after antibiotic therapy: comparison of cephradine and amoxycillin.
    McLinn SE
    J Int Med Res; 1979; 7(6):546-50. PubMed ID: 391628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.